UB
SGMO

UMB Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

UMB Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$134 – 2210
2024
Q1 		$134 Hold
200
– – ﹤0.01% 2130
2023
Q4 		$109 Hold
200
– – ﹤0.01% 1594
2023
Q3 		$120 Hold
200
– – ﹤0.01% 1674
2023
Q2 		$260 Hold
200
– – ﹤0.01% 1649
2023
Q1 		$352 Hold
200
– – ﹤0.01% 1658
2022
Q4 		$1K Hold
200
– – ﹤0.01% 1667
2022
Q3 		$1K Hold
200
– – ﹤0.01% 1705
2022
Q2 		$1K Hold
200
– – ﹤0.01% 1862
2022
Q1 		$1K Hold
200
– – ﹤0.01% 1933
2021
Q4 		$2K Buy
+200
New +$1.74K ﹤0.01% 1843

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UMB Bank's SGMO Position: Q2 2024 in Review

UMB Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 200 shares — an estimated $134 sold.

UMB Bank first reported a position in SGMO in Q4 2021 and held it in 10 quarters. The position peaked at $2K in Q4 2021. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • UMB Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • UMB Bank sold 200 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $134.
  • UMB Bank first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 10 quarters.
  • UMB Bank's SANGAMO THERAPEUTICS INC position peaked at $2K in Q4 2021.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on UMB Bank's 13F filing for Q2 2024, filed 29 Jul 2024.